Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of KSP-910638G for GI Malignancy Detection
NCT03161418Phase 1Completed
- Sponsor
- University of Michigan
- Start
- Jun 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of KSP-910638G in gastrointestinal cancer, sponsored by University of Michigan. Primary endpoint: Number of subjects with abnormal lab values at 48 hours. Started Jun 2017; status: completed.
02
Drugs
KSP-910638G
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT03161418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03161418.